Remission Rate in the Patients with Graves' Disease after Treatment with a Minimum Maintenance Dose of Methimazole for 12 Months

被引：0
|
作者：
Mutsuo, Beniko [1 ]
Hiroyuki, Ikawa [1 ]
Takayuki, Mori [1 ]
Yasuo, Mashio [2 ]
机构：
[1] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan
[2] Sapporo Kosei Kyosai Clin, Sapporo, Hokkaido, Japan
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-0471
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission
    Konishi, Toshiaki
    Okamoto, Yasuyuki
    Ueda, Miki
    Fukuda, Yoshiko
    Harusato, Ichiko
    Tsukamoto, Yuka
    Hamada, Noboru
    ENDOCRINE JOURNAL, 2011, 58 (02) : 95 - 100
  • [2] Practical treatment with minimum maintenance dose of anti-thyroid drugs for prediction of remission in Graves' disease
    Kashiwai, T
    Hidaka, Y
    Takano, T
    Tatsumi, KI
    Izumi, Y
    Shimaoka, Y
    Tada, H
    Takeoka, K
    Amino, N
    ENDOCRINE JOURNAL, 2003, 50 (01) : 45 - 49
  • [3] GRAVES-DISEASE - EVOLUTION AND PROGNOSIS AFTER 8 MONTHS OF TREATMENT WITH METHIMAZOLE
    GAUNA, AT
    GUILLEN, CE
    SARTORIO, GC
    SOTO, RJ
    MEDICINA-BUENOS AIRES, 1992, 52 (03) : 207 - 212
  • [4] Minimum Dosage of Methimazole at Discontinuation Is a Strong Index for Predicting Remission of Graves' Disease
    Liu, Xiaomei
    Qiang, Wei
    Liu, Xingjun
    Liu, Lianye
    Liu, Shu
    Gao, Aibo
    Gao, Shan
    Shi, Bingyin
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [5] Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study
    Benker, G
    Reinwein, D
    Kahaly, G
    Tegler, L
    Alexander, WD
    Fassbinder, J
    Hirche, H
    CLINICAL ENDOCRINOLOGY, 1998, 49 (04) : 451 - 457
  • [6] Remission of insulin autoimmune syndrome in a patient with Graves' disease by treatment with methimazole
    Okabe, R
    Inaba, M
    Hosoi, M
    Ishimura, E
    Kumeda, Y
    Nishizawa, Y
    Morii, H
    INTERNAL MEDICINE, 1999, 38 (06) : 482 - 485
  • [7] Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment
    Villagelin, Danilo
    Romaldini, Joao H.
    Santos, Roberto B.
    Milkos, Ana B. B. P.
    Ward, Laura S.
    THYROID, 2015, 25 (12) : 1282 - 1290
  • [8] The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease
    Tsuboi, Kumiko
    Ueshiba, Hajime
    Shimojo, Masako
    Ishikawa, Mayumi
    Watanabe, Natsuko
    Nagasawa, Kaoru
    Yuasa, Rena
    Yoshino, Gen
    ENDOCRINE JOURNAL, 2007, 54 (01) : 39 - 43
  • [9] Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13
    Komiya, I
    Yamada, T
    Sato, A
    Kouki, T
    Nishimori, T
    Takasu, N
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08): : 3540 - 3544
  • [10] Remission of Graves' disease is not related to early restoration of euthyroidism with high-dose methimazole therapy
    Kruljac, Ivan
    Solter, Darko
    Vrkljan, Ana Marija
    Solter, Miljenko
    ENDOCRINE RESEARCH, 2015, 40 (01) : 25 - 28
12345